NewsBeat
New NHS blood cancer pill could help patients live well for longer
Multiple myeloma, a type of blood cancer originating from abnormal plasma cells in the bone marrow, affects approximately 6,200 people in the UK each year. This promising new treatment specifically targets relapsed or refractory cases, where the cancer has either returned after remission or has ceased responding to previous therapies.
You must be logged in to post a comment Login